1. Identification of ligand binding sites in intrinsically disordered proteins with a differential binding score
- Author
-
Chen, Qiao-Hong and Krishnan, VV
- Subjects
Theory Of Computation ,Biological Sciences ,Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Information and Computing Sciences ,Rare Diseases ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Generic health relevance ,Binding Sites ,Biophysical Phenomena ,Biophysics ,Drug Discovery ,Humans ,Intrinsically Disordered Proteins ,Ligands ,Models ,Statistical ,Molecular Dynamics Simulation ,Protein Binding ,Protein Conformation ,Protein Domains ,Proteins ,Tumor Suppressor Protein p53 - Abstract
Screening ligands directly binding to an ensemble of intrinsically disordered proteins (IDP) to discover potential hits or leads for new drugs is an emerging but challenging area as IDPs lack well-defined and ordered 3D-protein structures. To explore a new IDP-based rational drug discovery strategy, a differential binding score (DIBS) is defined. The basis of DIBS is to quantitatively determine the binding preference of a ligand to an ensemble of conformations specified by IDP versus such preferences to an ensemble of random coil conformations of the same protein. Ensemble docking procedures performed on repeated sampling of conformations, and the results tested for statistical significance determine the preferential ligand binding sites of the IDP. The results of this approach closely reproduce the experimental data from recent literature on the binding of the ligand epigallocatechin gallate (EGCG) to the intrinsically disordered N-terminal domain of the tumor suppressor p53. Combining established approaches in developing a new method to screen ligands against IDPs could be valuable as a screening tool for IDP-based drug discovery.
- Published
- 2021